Young Women Less Likely Than Men to Start Meds After AMI

This article originally appeared here.
Share this content:
Young Women Less Likely Than Men to Start Meds After AMI
Young Women Less Likely Than Men to Start Meds After AMI

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- After acute myocardial infarction (AMI), younger women are less likely than younger men to initiate prescribed medications, according to a study published online Oct. 13 in Circulation: Cardiovascular Quality and Outcomes.

Kate Smolina, Ph.D., from the University of British Columbia, and colleagues analyzed linked administrative data sets (health care, prescription drugs, sociodemographic, and mortality information) in British Columbia to identify individuals who were admitted to the hospital for AMI (2007 to 2009) and survived for one year after discharge.

The researchers found that more than two-thirds of AMI survivors initiated treatment on all appropriate medications, given their contraindications, within two months of discharge. Appropriate treatment was significantly more likely to be initiated by younger men than younger women (adjusted odds ratio, 1.38). Only one-third of all AMI survivors filled all appropriate prescriptions for at least 80 percent of the first year after discharge. There was no significant difference in therapy adherence between women and men.

"Overall, the majority of AMI survivors either discontinue treatment or do not refill their prescriptions consistently, suggesting that further improvements in post-AMI therapy management are necessary," write the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »